Breaking News Instant updates and real-time market news.

CTIC

CTI BioPharma

$0.90

-0.0447 (-4.73%)

, TEVA

Teva

$18.22

-0.13 (-0.71%)

07:10
02/11/19
02/11
07:10
02/11/19
07:10

CTI BioPharma receives $10M milestone payment for TRISENOX from Teva

CTI BioPharma (CTIC) announced that it has received a $10M milestone payment from Teva (TEVA) related to the achievement of sales milestones for TRISENOX. TRISENOX was acquired from CTI BioPharma by Cephalon. Cephalon was subsequently acquired by Teva. The milestone was paid pursuant to an acquisition agreement for TRISENOX entered into with Cephalon under which CTI BioPharma is eligible to receive up to an additional $40M in payments upon achievement by Teva of specified sales and development milestones related to TRISENOX.

CTIC

CTI BioPharma

$0.90

-0.0447 (-4.73%)

TEVA

Teva

$18.22

-0.13 (-0.71%)

  • 13

    Feb

CTIC CTI BioPharma
$0.90

-0.0447 (-4.73%)

03/07/18
03/07/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Marvell (MRVL) initiated with a Buy at Argus. 2. Barrett Business (BBSI) resumed with a Buy at Roth Capital. 3. Impax (IPXL) initiated with a Buy at SunTrust. 4. CTI BioPharma (CTIC) initiated with an Outperform at JMP Securities. 5. Mindbody (MB) initiated with a Buy at Summit Insights. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
03/26/18
NEED
03/26/18
INITIATION
Target $10
NEED
Buy
CTI BioPharma initiated with a Buy at Needham
Needham analyst Chad Messer initated CTI BioPharma with a Buy rating and a price target of $10, citing his view of pacritinib as an unusually de-risked asset based on the data from two Phase III studies and a "clear path to approval with the FDA". Messer adds that despite some recent recovery in the stock price, there is still "deep value" in CTI BioPharma shares. The analyst further notes the company's commercial presence with Pixuvri as a treatment in aggressive B-cell NHL which has a conditional approval in Europe.
03/26/18
03/26/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Altria Group (MO) initiated with a Buy at Deutsche Bank. 2. Sage Therapeutics (SAGE) assumed with a Buy at Canaccord. 3. Essa Pharma (EPIX) initiated with a Buy at H.C. Wainwright. 4. CTI BioPharma (CTIC) initiated with a Buy at Needham. 5. Saia (SAIA) initiated with a Buy at Buckingham. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
07/10/18
JMPS
07/10/18
NO CHANGE
Target $8
JMPS
Outperform
CTI BioPharma only had modest pixantrone opportunity in EU, says JMP Securities
After CTI BioPharma announced that a Phase 3 study of pixantrone in B-cell non-Hodgkin lymphoma failed to meet its primary endpoint, JMP Securities analyst Konstantinos Aprilakis said that his projections for the drug in that indication in the EU were modest and removing it from his model did not change his $8 price target on the stock. Pacritinib and the "tremendous opportunity" for it in myelofibrosis have always been central to his investment thesis for CTI, added Aprilakis, who maintains an Outperform rating on the stock, which fell 14% to close at $4.48 on Monday.
TEVA Teva
$18.22

-0.13 (-0.71%)

01/23/19
01/23/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Walmart (WMT) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Simeon Gutman citing his belief that Walmart U.S. can now generate sales growth without sacrificing margins, unlike most retailers. 2. Teva (TEVA) upgraded to Buy from Neutral at UBS and to Neutral from Underweight at Piper Jaffray. 3. D.R. Horton (DHI) upgraded to Buy from Neutral at Mizuho with analyst Haendel St. Juste saying stock selectivity is becoming more important in these latter stages of the housing cycle and larger platforms with price point diversification and strong balance sheets will be rewarded. 4. Logitech (LOGI) upgraded to Overweight from Neutral at JPMorgan and to Hold from Sell at Maxim. 5. Lamb Weston (LW) upgraded to Buy from Hold at Stifel with analyst Christopher Growe saying he is confident in the "growth profile of the business continuing amidst the very strong operating conditions in the category." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/25/19
PIPR
01/25/19
NO CHANGE
PIPR
Report that CVS excluded Amgen's Aimovig 'greatly exaggerated,' says Piper
Piper Jaffray analyst Christopher Raymond kept an Overweight rating and $220 price target on Amgen (AMGN) following a Reuters report from earlier on Friday which stated that CVS (CVS) has excluded Amgen's Aimovig from its formulary. The analyst called the report "Friday afternoon clickbait" and noted that while CVS currently provides preferred status to Teva's (TEVA) Ajovy and Eli Lilly's (LLY) Emgality, this was made public in late 2018. In a check with management, Raymond found out the decision only encompasses about one-third of CVS network, that CVS is actively working to improve this access, and that 70% of commercial migraine patients have contracted access to Aimovig. Raymond concluded that this was "not something to worry about" in his view, and did not change his Q4, FY19, or FY20 estimates on Aimovig. In Friday trading, shares of Amgen were down just over 1% to $198.77.
01/30/19
WELS
01/30/19
NO CHANGE
WELS
Wells says Novartis report read-through 'neutral to negative' for Mylan, Teva
After Novartis' (NVS) Sandoz generics unit reported Q4 sales were down 2% in constant currency, due to a 7% decline in price and 5% increase in volume, Wells Fargo analyst David Maris noted that the majority of the price erosion came from the U.S. While the 2% decline was a sequential improvement from down 4% in Q3, Novartis was up against an easy comparison in the year ago period, Maris added. His view is that the U.S. generic market has not materially changed or improved at this point and he contends the report has a "neutral to negative read-through" relative to investors' expectations for Mylan (MYL) and Teva (TEVA).
02/01/19
WELS
02/01/19
NO CHANGE
Target $46
WELS
Market Perform
Perrigo's ProAir opportunity 'may be vaporizing,' says Wells Fargo
Wells Fargo analyst David Maris noted that GlaxoSmithKline (GSK) launched an authorized generic of Ventolin on January 15 and he has now learned that Teva (TEVA) may have "surprisingly launched" an authorized generic of ProAir in response to the generic Ventolin pressure prior to Perrigo's (PRGO) approval. Pricing pressure from generic Ventolin, in addition to the launch of an authorized generic well ahead of Perrigo's own generic ProAir launch, seem to have significantly diminished Perrigo's generic ProAir opportunity, Maris tells investors. He keeps a Market Perform rating and $46 price target on Perrigo shares.

TODAY'S FREE FLY STORIES

MAT

Mattel

$11.62

-0.435 (-3.61%)

13:02
06/19/19
06/19
13:02
06/19/19
13:02
Hot Stocks
MGA calls off Mattel merger talks, says 'too much mess to clean up' »

MGA Entertainment CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEVA

Teva

$8.30

-0.045 (-0.54%)

13:01
06/19/19
06/19
13:01
06/19/19
13:01
Hot Stocks
Teva announces U.S. launch of generic version of Tracleer »

Teva Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Z

Zillow

$45.36

-1.1 (-2.37%)

13:00
06/19/19
06/19
13:00
06/19/19
13:00
Options
Zillow put buyer opens new short-term position »

Zillow put buyer opens…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MAT

Mattel

$11.62

-0.43 (-3.57%)

12:59
06/19/19
06/19
12:59
06/19/19
12:59
Hot Stocks
Breaking Hot Stocks news story on Mattel »

MGA Entertainment CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHS

Chico's

$3.24

0.14 (4.52%)

12:56
06/19/19
06/19
12:56
06/19/19
12:56
Hot Stocks
Sycamore Partners lowers takeover offer to Chico's to $3.00 per share »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBAY

CymaBay

$7.00

-0.09 (-1.27%)

12:55
06/19/19
06/19
12:55
06/19/19
12:55
Options
CymaBay put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MAT

Mattel

$11.58

-0.47 (-3.90%)

12:55
06/19/19
06/19
12:55
06/19/19
12:55
Hot Stocks
Breaking Hot Stocks news story on Mattel »

MGA Entertainment says no…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KKR

KKR

$23.93

0.57 (2.44%)

12:50
06/19/19
06/19
12:50
06/19/19
12:50
Periodicals
KKR close to selling partial stake in $2B helicopter firm, Bloomberg says »

According to Elffie Chew…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHS

Chico's

$3.24

0.14 (4.52%)

12:49
06/19/19
06/19
12:49
06/19/19
12:49
Hot Stocks
Chico's erases gains after Bloomberg says Sycamore again lowered bid »

Chico's in midday…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHS

Chico's

$3.25

0.145 (4.68%)

12:48
06/19/19
06/19
12:48
06/19/19
12:48
Periodicals
Sycamore Partners lowers bid for Chico's to $3 per share, Bloomberg reports »

Sycamore Partners has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GIS

General Mills

$52.59

0.15 (0.29%)

12:45
06/19/19
06/19
12:45
06/19/19
12:45
Options
General Mills call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 09

    Jul

  • 10

    Jul

  • 11

    Jul

BIDU

Baidu

$117.13

0.26 (0.22%)

12:41
06/19/19
06/19
12:41
06/19/19
12:41
Periodicals
Baidu says Apollo Lite framework achieves level 4 autonomy, VB reports »

According to VB's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

KR

Kroger

$23.62

-0.32 (-1.34%)

, DRI

Darden

$116.14

-1.8 (-1.53%)

12:35
06/19/19
06/19
12:35
06/19/19
12:35
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

KR

Kroger

$23.62

-0.32 (-1.34%)

DRI

Darden

$116.14

-1.8 (-1.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

  • 20

    Jun

  • 25

    Jun

  • 27

    Jun

MDR

McDermott

$7.69

0.065 (0.85%)

12:35
06/19/19
06/19
12:35
06/19/19
12:35
Options
McDermott put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:35
06/19/19
06/19
12:35
06/19/19
12:35
General news
FOMC forecast preview: »

FOMC forecast preview:…

ORCL

Oracle

$52.80

-0.08 (-0.15%)

12:35
06/19/19
06/19
12:35
06/19/19
12:35
Earnings
Notable companies reporting after market close »

Notable companies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

GME

GameStop

$5.65

-0.08 (-1.40%)

, ATVI

Activision Blizzard

$45.02

-0.76 (-1.66%)

12:33
06/19/19
06/19
12:33
06/19/19
12:33
Hot Stocks
GameStop says new 'Call of Duty' most pre-ordered video game following E3 »

GameStop (GME) said that…

GME

GameStop

$5.65

-0.08 (-1.40%)

ATVI

Activision Blizzard

$45.02

-0.76 (-1.66%)

NTDOY

Nintendo

$0.00

(0.00%)

TTWO

Take-Two

$109.38

-1.61 (-1.45%)

EA

Electronic Arts

$92.38

0.35 (0.38%)

MSFT

Microsoft

$134.54

-0.66 (-0.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

  • 20

    Jun

  • 23

    Jun

  • 25

    Jun

  • 09

    Jul

  • 10

    Jul

  • 06

    Aug

  • 13

    Nov

INO

Inovio

$2.61

-0.02 (-0.76%)

12:25
06/19/19
06/19
12:25
06/19/19
12:25
Conference/Events
Inovio management to meet with Piper Jaffray »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

SHOP

Shopify

$316.25

11.94 (3.92%)

12:25
06/19/19
06/19
12:25
06/19/19
12:25
Conference/Events
Shopify to host investor day »

Investor day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 05

    Sep

EVBG

Everbridge

$89.89

1.36 (1.54%)

12:25
06/19/19
06/19
12:25
06/19/19
12:25
Conference/Events
Everbridge to host analyst & investor meeting »

Analyst & Investor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

AAXN

Axon

$67.30

1.28 (1.94%)

12:24
06/19/19
06/19
12:24
06/19/19
12:24
Periodicals
Breaking Periodicals news story on Axon »

Axon tells Bloomberg…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

IOVA

Iovance Biotherapeutics

$22.23

-0.15 (-0.67%)

12:23
06/19/19
06/19
12:23
06/19/19
12:23
Conference/Events
Iovance Biotherapeutics management to meet with Piper Jaffray »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 26

    Jun

FB

Facebook

$185.75

-2.71 (-1.44%)

, AMZN

Amazon.com

$1,900.94

-1.06 (-0.06%)

12:18
06/19/19
06/19
12:18
06/19/19
12:18
On The Fly
#SocialStocks: Facebook announces blockchain currency »

Welcome to…

FB

Facebook

$185.75

-2.71 (-1.44%)

AMZN

Amazon.com

$1,900.94

-1.06 (-0.06%)

GOOG

Alphabet

$1,097.93

-6.47 (-0.59%)

AAPL

Apple

$198.14

-0.38 (-0.19%)

TWTR

Twitter

$36.04

-0.6 (-1.64%)

SNAP

Snap

$14.60

-0.26 (-1.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 19

    Jun

  • 25

    Jun

  • 09

    Jul

  • 10

    Jul

  • 27

    Oct

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
06/19/19
06/19
12:17
06/19/19
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
06/19/19
06/19
12:16
06/19/19
12:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.